Program Details

General Details

Saturday, November 21, 2020

8:00 – 10:00 AM CST 

 

Location

Virtual Program. Link will be sent to registered participants.

Pre-Requisite Materials

The Advanced Intermediate or Advanced HCC Patient (Local Vascular Invasion/Classification/Prognosis): Who are They? 

by Dr. Ahsun Riaz, Northwestern Medicine

Imaging after Loco-Regional Therapy

by Dr. Chuck Ray, University of Illinois

Local Vascular Invasion: Chemoembolization  +/- DEBs

by Dr. Ron Gaba, University of Illinois

Local Vascular Invasion: Radioembolization

by Dr. Jordan Tasse, Rush University

Local Vascular Invasion: Ablation and Resection

by Dr. Talia Baker, University of Chicago

Presenters

Osman Ahmed, MD

Dr. Osman Ahmed is currently an Assistant Professor in the section of Vascular and Interventional Radiology at the University of Chicago. He completed medical training at the University of Illinois College of Medicine before attending the University of Chicago for Diagnostic Radiology residency. He subsequently completed his VIR fellowship at Stanford in 2015.

Dr. Ahmed has been recognized as a leader in the community of IR, having recently been selected to attend the SIR’s leadership and development academy and 2020 recipient of the Gary Becker Young Investigator Award. He also contributes as Social Media Editor for SIR’s flagship editorial, the Journal of Vascular and Interventional Radiology. He has also been recognized by the journal as a Top Reviewer for the years 2016-2018. His clinical and research interests include catheter-based treatments for venous thromboembolism, caval filter retrieval, musculoskeletal interventions, health economics, embolization, and interventional oncology.

Jessica Andreoli, MD

Jessica Andreoli, MD is a Vascular & Interventional Radiology Specialist in Winfield, IL. She is affiliated with Northwestern Medicine Central DuPage Hospital and Northwestern Medicine Delnor Hospital. Dr. Andreoli graduated from Boston University School of Medicine in 2012. She completed her Diagnostic Radiology Residency and Vascular and Interventional Radiology Fellowship at Northwestern University.

Bulent Arslan, MD

Dr. Bulent Arslan is an interventional radiologist in Chicago, Illinois at Rush University Medical Center.  He is a Professor and Director of Vascular and Interventional Radiology and Chair of Interventional Platform Quality Assurance Program.

He graduated from Marmara University School of Medicine, İstanbul Turkey in 1992. He completed his residency and fellowship at University of Rochester, NY. Prior to his appointment at Rush University he worked at Moffitt Caner Cerrahpaşa Center and Research Institute, where he developed a very busy interventional oncology program.

His clinical interests are interventional oncology (specifically Y-90 Radioembolization), portal hypertension, and endovascular management of aortic and peripheral vascular disease.

He has given over 200 national and international talks and published over 250 abstracts, invited and peer reviewed manuscripts.

Talia Baker, MD

Talia Baker, MD, is the director of the Living Donor Liver Transplant Program and the Surgical and Program director of the Liver Transplant Program at UChicago Medicine. She is a nationally-recognized leader in living donor liver transplantation and the treatment of liver diseases, including complex hepatobiliary malignancies.
Dr. Baker is an active researcher. Her scholarly work focuses on liver transplant topics, such as downstaging complex hepatobiliary tumors to resectability and the ethical implications of using social media for organ donation opportunities. Dr. Baker was an invited participant at the 2016 White House summit to reduce the organ waiting list and facilitate research breakthroughs.

George Behrens, MD

George Behrens, MD trained in diagnostic radiology at the University of Caracas, in his home country of Venezuela. He completed a surgery internship at Rush University Medical Center in Chicago, then a year of fellowship in interventional radiology at Rush. He is Board certified in radiology by the ABR.
Dr. Behrens is trained in interventional oncology (image guided treatment of cancer), and has a particular interest in non-surgical treatment of liver disease. He has done research in non-surgical treatment of portal hypertension during his fellowship. He has been the author of numerous research papers and book chapters on liver disease, arterial disease, and venous conditions.

Brian Funaki, MD

Dr. Brian Funaki is currently is Professor of Radiology and Chief of Vascular and Interventional Radiology at the University of Chicago. He graduated Phi Beta Kappa with a double major from Johns Hopkins University in 1988. He attended medical school at Washington University in St. Louis and was elected to Alpha Omega Alpha medical honor society in 1992. He completed a radiology residency and fellowship in Interventional Radiology at the University of Chicago and joined the faculty in 1998.
Dr. Funaki is former editor of Seminars in Interventional Radiology and a current associate editor of the Journal of Vascular and Interventional Radiology. He served as chair of the American College of Radiology Appropriateness Criteria Expert Panel on Interventional Radiology. He is a fellow of the Society of Interventional Radiology, Cardiovascular and Interventional Society of Europe and American Heart Association. He has held numerous positions in the Society of Interventional Radiology including Annual Meeting Chair. He has over 200 publications listed on PubMed and has delivered over 150 invited lectures.

Ron C. Gaba MD, MS

Dr. Ron C. Gaba joined the Department of Radiology, Division of Interventional Radiology at the University of Illinois at Chicago in 2008. He is an Associate Professor, Division Head of Interventional Radiology, Vice Head for Research in Radiology, and Director of Medical Student Research at the University of Illinois at Chicago College of Medicine. Dr. Gaba is active in clinical service and patient care, trainee education, and clinical and translational research. Dr. Gaba’s federally funded research interests include Interventional Oncology (transarterial chemoembolization, drug delivery, animal models of disease, and precision medicine and genomics) and portal hypertension (transjugular intrahepatic portosystemic shunts and variceal therapy with embolization or obliteration). Dr. Gaba earned his medical degree from the University of Michigan in 2002, completed a Diagnostic Radiology residency at the University of Illinois at Chicago in 2007, trained in Vascular and Interventional Radiology at Northwestern University in 2008, and completed a Master’s degree in Clinical and Translational Science at the University of Illinois at Chicago in 2019.

Aparna Kalyan, MD

Aparna Kalyan, MD is an Assistant Professor of Medicine (Hematology and Oncology) at Northwestern University She earned her MBBS in 2005 from Flinders University of South Australia, Australia; performed her residency at St. Vincent’s Hospital, Melbourne Australia, Internal Medicine (2009) and University Hospitals Case Medical Center, Cleveland OH, Internal Medicine (2011), and her fellowship in Hematology / Oncology at University of Pittsburgh Medical Center (2014). She then completed a dedicated developmental therapeutics fellowship at Northwestern University. She currently is the Co-lead for the GI Oncology Disease team at Northwestern.

Her primary interests are in developing novel therapeutic combinations for the treatment of gastrointestinal cancers. She is interested in incorporating Immunotherapy, molecular testing and local regional therapies for management of hepatobiliary cancers.

Laura Kulik, MD

Laura Kulik, MD, is an Associate Professor of Medicine at Northwestern since July 2003. She attended medical school, residency, and completed her fellowship at University of Illinois. Dr. Kulik’s clinical interests include HCC, liver directed therapy for HCC, and liver transplant for HCC.

Robert J. Lewandowski, MD, FSIR

Robert J. Lewandowski, M.D., FSIR, is a Professor of Radiology, Medicine, and Surgery in the Feinberg School of Medicine at Northwestern University. He serves as the Director of Interventional Oncology at the Northwestern University Robert H. Lurie Comprehensive Cancer Center. Dr. Lewandowski joined the staff at Northwestern in 2006 upon completion of his fellowship training in Vascular and Interventional Radiology. Dr. Lewandowski is a practicing interventional radiologist who specializes in liver-directed therapy for patients with primary or secondary malignancies of the liver. Based on his clinical oncology program, he has authored or co-authored > 150 articles for peer-reviewed journals on the application of liver-directed therapies for patients with gastrointestinal malignancies. Dr. Lewandowski also performs pre-clinical oncology research in the Northwestern University Interventional Oncology Laboratory and Center for Translational Imaging. In this capacity, he is developing and evaluating novel oncology therapeutics, delivery mechanisms, and imaging modalities. Dr. Lewandowski’s research work has been supported by the National Institute of Health, American Cancer Society, the Society of Interventional Radiology Foundation, and through industry collaboration via the investigator-initiated trial mechanism.

Christopher Molvar, MD

Christopher Molvar, MD is an Associate Professor of Vascular & Interventional Radiology at Loyola University Medical Center. He is the Director of Interventional Oncology with interests in the treatment of primary and secondary liver tumors, along with the management of portal hypertension.

Dr. Molvar completed medical school at the University of Chicago, followed by a Diagnostic Radiology Residency also at the University of Chicago. At Northwestern Memorial Hospital, he completed fellowship training in Vascular & Interventional Radiology.

Ahsun Riaz, MD

Ahsun Riaz, MD is a Vascular & Interventional Radiology Specialist in Grayslake, IL. He is affiliated with medical facilities Northwestern Medicine Lake Forest Hospital and Northwestern Memorial Hospital.

His clinical and research interests include hepatobiliary (liver tumor treatment, biliary interventions, and portal hypertension), thoracic (lung tumor diagnosis and treatment), splenic (interventions for thrombocytopenia/aneurysms), and lymphatic disease.

Charles E. Ray, Jr., MD

Dr. Charles E. Ray, Jr. currently is Chair and Professor of Radiology. He received a combined MD/MS (Anatomy) from Rush University, as well as a PhD in Clinical Science from the University of Colorado. Following a diagnostic radiology residency at the University of Illinois, he completed a fellowship in vascular/interventional radiology at the Massachusetts General Hospital. Before accepting his permanent position as Professor and Head of Radiology at the University of Illinois, his prior positions included: section head of angio/interventional radiology at Roswell Park Cancer Institute; chief of interventional radiology at Denver Health Medical Center; and chief of interventional radiology at the University of Colorado.
Dr. Ray’s areas of research involve clinical research in the field of interventional oncology, particularly locoregional treatment of liver malignancies. He has a particular interest in cost analysis of oncologic interventions.
Dr. Ray has published >350 articles, abstracts, and book chapters, as well as 14 books and monographs. He has delivered >325 lectures worldwide on a variety of topics related to the field of interventional radiology. He has received fellowship in the American College of Radiology, the Society of Interventional Radiology, and the Cardiovascular and Interventional Society of Europe. He has served as President of the Society of Interventional Radiology, President of the Colorado Radiological Society, and President of the Rocky Mountain Radiological Society. He is the current Editor-in-Chief of Seminars in Interventional Radiology.

Riad Salem, MD, MBA

Riad Salem, MD MBA is a Vice-Chair, Image-Guided Therapy and Chief, Interventional Radiology and Oncology in the Department of Radiology at Northwestern University (Chicago). His areas of interest include the use of image-guided techniques for the treatment of malignancies. These include chemoembolisation, bland embolisation, radioembolisation, radiofrequency and cryo/alcohol ablation. He is a graduate of McGill University in Montreal, Canada. He completed his radiology residency in Washington, DC. He has also completed a fellowship in interventional radiology (University of Pennsylvania), as well as a Master’s in Business Administration (Finance). He is a member of Alpha Omega Alpha medical honor society and a Fellow of the Society of Interventional Radiology. He has lectured internationally and published extensively on the subject of image-guided interventions and interventional oncology. Recently, he completed his term on the NCCN guidelines panel for hepatocellular carcinoma (2007-2010). His current research focus on hepatocellular carcinoma includes advances in minimally invasive therapies as well as imaging methodologies following locoregional treatment. He serves as co-PI of 2 international, randomised phase III trials involving locoregional therapy (radioembolisation) and sorafenib (STOP-HCC, YES-p).

Jordan Tasse, MD

Dr. Tasse is originally from Cleveland and came to Chicago for medical school and has been here ever since. He completed medical school at Chicago Medical School and radiology residency at Loyola University Medical Center. He then went to Rush University Medical Center for vascular and interventional radiology fellowship. After completion of his fellowship, he joined the faculty at Rush and has been practicing there for 7 years. He is currently the director of interventional oncology and the program director for the IR residency program at Rush.

Steven M Zangan MD, FSIR

Steven M Zangan MD, FSIR, is an Associate Professor of Radiology and Transplant Surgery at the University of Chicago. As Vice-Chair for Business Development, he oversees the growth and development of multiple service lines offered by the Radiology Department. He serves as the Associate Program Director of the Interventional Radiology Residency and as Ombudsman for the University of Chicago Pritzker School of Medicine. With clinical, research and educational expertise in Interventional Oncology, he is a frequent lecturer on emerging topics in liver directed therapies.

Event Schedule

2/12/2020 – 11/20/2020

Online Registration

11/21/2020

Event Program

Opening Remarks and Session 1 Moderators: Dr. Bulent Arslan, Rush University and Dr. Chris Molvar, Loyola University

Session 1: Review of Pre-requisite Materials (these materials were pre-recorded and will be discussed)

8:00 – 8:20 AM

The Advanced Intermediate or Advanced HCC Patient (Local Vascular Invasion/Classification/Prognosis): Who are They?

Recorded by Dr. Ahsun Riaz, Northwestern Medicine

Imaging after Loco-Regional Therapy

 

Recorded by Dr. Chuck Ray, University of Illinois

Local Vascular Invasion: Chemoembolization +/- DEBs

Recorded by Dr. Ron Gaba, University of Illinois

Local Vascular Invasion: Radioembolization

Recorded by Dr. Jordan Tasse, Rush University

Local Vascular Invasion: Ablation and Resection

Recorded by Dr. Talia Baker, University of Chicago

Session 2 Moderators: Dr. Robert Lewandowski, Northwestern Medicine and Dr. Brian Funaki, University of Chicago

8:20 – 8:40 AM

Update on Systemic Therapy for HCC:  Current Data, Expanding Applications, and remaining Unmet Needs

Dr. Aparna Kalyan, Northwestern Medicine

8:40 – 8:50 AM

When to Transition from LDT to Systemic Therapy (and vice versa)

Dr. Riad Salem, Northwestern University

8:50 – 9:00 AM

Current Evidence for Combining Systemic and Liver-Directed Therapies and Future Opportunities for Liver-Directed Therapy in Advanced Disease

Dr. Steven Zangan, University of Chicago

Session 3 Moderator: Dr. Laura Kulik, Northwestern Medicine and Dr. Riad Salem, Northwestern Medicine

9:00 – 9:10 AM

9:10 – 9:20 AM

9:20 – 9:30 AM

Case Examples/Discussion

  • Dr. Jessica Andreoli, Northwestern Medicine
  • Dr. George Behrens, Amita Health
  • Dr. Osman Ahmed, University of Chicago

Closing Remarks: Dr. Robert Lewandowski, Northwestern Medicine